Biomx Financial Statements From 2010 to 2026

PHGE Stock  USD 5.11  0.12  2.29%   
Biomx's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Biomx's valuation are provided below:
Market Capitalization
8.1 M
Earnings Share
(37.05)
There are over one hundred nineteen available fundamental signals for Biomx Inc, which can be analyzed over time and compared to other ratios. Investors should ensure to validate all of Biomx's prevailing performance against the performance from 2010 to 2026 to make sure the company is sustainable down the road. As of February 22, 2026, Market Cap is expected to decline to about 124 M. In addition to that, Enterprise Value is expected to decline to about 120.7 M
Check Biomx financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Biomx's main balance sheet or income statement drivers, such as Interest Expense of 19 K, Selling General Administrative of 8.2 M or Research Development of 17 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. Biomx financial statements analysis is a perfect complement when working with Biomx Valuation or Volatility modules.
  
Build AI portfolio with Biomx Stock
Check out the analysis of Biomx Correlation against competitors.

Biomx Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets41.4 M38.9 M34.8 M
Slightly volatile
Short and Long Term Debt Total1.4 M1.4 M4.4 M
Slightly volatile
Other Current Liabilities3.3 M1.8 M2.4 M
Slightly volatile
Total Current Liabilities7.5 M6.4 M4.6 M
Slightly volatile
Other Liabilities2.6 M2.5 M1.3 M
Slightly volatile
Net Tangible Assets53.3 M52.9 M33.4 M
Slightly volatile
Property Plant And Equipment Net6.6 M12.1 M4.3 M
Slightly volatile
Accounts Payable1.9 M3.1 MM
Slightly volatile
Cash34.5 M20.5 M20.9 M
Slightly volatile
Non Current Assets Total27.4 M26.1 M10 M
Slightly volatile
Cash And Short Term Investments31.5 M16 M24.7 M
Slightly volatile
Net Receivables1.4 M1.3 M542.7 K
Slightly volatile
Common Stock Total Equity1.7 K1.8 K3.9 M
Very volatile
Common Stock Shares Outstanding1.7 B1.6 B238.4 M
Slightly volatile
Liabilities And Stockholders Equity5.5 M5.8 M30.8 M
Slightly volatile
Non Current Liabilities Total670.7 K706 K4.4 M
Slightly volatile
Capital Surpluse156.6 M149.2 M63.9 M
Slightly volatile
Other Current Assets2.3 M1.8 M1.3 M
Slightly volatile
Total Liabilities6.7 M7.1 MM
Slightly volatile
Deferred Long Term Liabilities3.3 M2.7 M3.9 M
Slightly volatile
Net Invested Capital4.7 MM18.4 M
Slightly volatile
Short and Long Term Debt3.7 M6.7 M2.6 M
Slightly volatile
Total Current Assets33.5 M18.5 M26.3 M
Slightly volatile
Short Term Debt2.2 M1.4 M1.1 M
Slightly volatile
Common Stock6.7 KK3.9 M
Very volatile
Property Plant Equipment11.9 M11.3 M4.8 M
Slightly volatile
Long Term Debt8.5 M6.2 M4.9 M
Slightly volatile
Property Plant And Equipment Gross19.3 M18.4 M5.9 M
Slightly volatile
Capital Stock22.5 M21.4 M3.7 M
Slightly volatile
Non Current Liabilities Other65.8 K69.3 K591.6 K
Slightly volatile
Intangible Assets14.6 M13.9 M6.7 M
Slightly volatile
Long Term Debt TotalM4.5 M4.9 M
Slightly volatile

Biomx Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Selling General Administrative8.2 M9.6 M5.1 M
Slightly volatile
Research Development17 M21.3 M10.5 M
Slightly volatile
Total Operating Expenses25.5 M30.9 M15.8 M
Slightly volatile
Depreciation And Amortization1.2 M2.1 M766.2 K
Slightly volatile
Other Operating Expenses27.8 M44.9 M19.2 M
Slightly volatile
Cost Of Revenue1.5 M2.1 M867.8 K
Slightly volatile
Interest Income761.3 K1.2 M820.9 K
Pretty Stable
Reconciled Depreciation1.7 M2.1 M961.3 K
Slightly volatile
Selling And Marketing Expenses834.5 KM649.2 K
Slightly volatile
Non Operating Income Net Other137.6 K154.8 K169 K
Slightly volatile

Biomx Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation1.5 M2.9 M890 K
Slightly volatile
Total Cash From Financing Activities21.1 M13.2 M13.6 M
Slightly volatile
End Period Cash Flow4.7 MM18 M
Slightly volatile
Change To Netincome1.5 M770.5 K915.2 K
Slightly volatile
Begin Period Cash Flow28.8 M18 M19.6 M
Slightly volatile
Stock Based CompensationM2.1 M1.4 M
Slightly volatile
Issuance Of Capital Stock10.5 M19.2 M27 M
Slightly volatile
Cash Flows Other Operating1.2 M1.4 M1.5 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Book Value Per Share0.860.904717.9722
Very volatile
Average Payables1.6 M1.5 M778.9 K
Slightly volatile
Capex To Depreciation7.0E-47.0E-44.6103
Slightly volatile
Payables Turnover1.720.93652.363
Slightly volatile
Cash Per Share0.06740.07117.25
Very volatile
Days Payables Outstanding232390237
Slightly volatile
Income Quality0.770.7290.8142
Slightly volatile
Intangibles To Total Assets0.00280.0030.1093
Pretty Stable
Current Ratio0.830.8746.4293
Pretty Stable
Tangible Book Value Per Share0.860.901717.0872
Very volatile
Capex Per Share0.00.00.6715
Slightly volatile
Interest Debt Per Share0.03290.03472.7075
Slightly volatile
Debt To Assets0.01940.02040.0988
Slightly volatile
Days Of Payables Outstanding232390237
Slightly volatile
Ebt Per Ebit1.011.09970.9079
Pretty Stable
Long Term Debt To Capitalization0.320.570.3112
Slightly volatile
Total Debt To Capitalization11.2510.71641.4121
Slightly volatile
Quick Ratio0.830.8746.4304
Pretty Stable
Cash Ratio0.740.77684.4057
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.161.00011.1228
Slightly volatile
Debt Ratio0.01940.02040.0988
Slightly volatile

Biomx Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap124 M130.5 M1.3 B
Slightly volatile
Enterprise Value120.7 M127 M1.3 B
Slightly volatile

Biomx Upcoming Events

3rd of April 2024
Upcoming Quarterly Report
View
20th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
3rd of April 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Biomx Financial Statements

Biomx stakeholders use historical fundamental indicators, such as Biomx's revenue or net income, to determine how well the company is positioned to perform in the future. Although Biomx investors may analyze each financial statement separately, they are all interrelated. For example, changes in Biomx's assets and liabilities are reflected in the revenues and expenses on Biomx's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Biomx Inc. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue32.2 K30.6 K
Cost Of Revenue2.1 M1.5 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Biomx Inc is a strong investment it is important to analyze Biomx's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Biomx's future performance. For an informed investment choice regarding Biomx Stock, refer to the following important reports:
Check out the analysis of Biomx Correlation against competitors.
You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Will Biotechnology sector continue expanding? Could Biomx diversify its offerings? Factors like these will boost the valuation of Biomx. Anticipated expansion of Biomx directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Biomx data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
(37.05)
Return On Assets
(0.79)
Return On Equity
(3.17)
Investors evaluate Biomx Inc using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Biomx's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Biomx's market price to deviate significantly from intrinsic value.
It's important to distinguish between Biomx's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Biomx should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Biomx's market price signifies the transaction level at which participants voluntarily complete trades.